Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Dri Healthcare Trust T.DHT.UN

Alternate Symbol(s):  DHTRF

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence... see more

TSX:DHT.UN - Post Discussion

Dri Healthcare Trust > Halted for what?
View:
Post by Marley66 on Jul 07, 2023 1:02pm

Halted for what?

Hopefully they will annonce a new royalty acquisition that is very accretive to current unitholder.
unfortunatly, it smell a secondary issue....or let's hope it's both of it
Comment by HermannHaller on Jul 07, 2023 1:50pm
Great news, too bad no one is around on a Friday afternoon in July to see it. After the previous royalty deal, RBC analyst estimated they had $200-250 million in liquidity available. This deal is $66 million, so still plenty of fuel in the tank.
Comment by raybay_98 on Jul 07, 2023 1:56pm
Agreed!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities